Next report date
Report period
Q1 2024
EPS estimate
−0.29USD
Revenue estimate
—
−59.08 MUSD
40.78 M
Om Galera Therapeutics, Inc.
Sektor
Bransch
VD
J. Mel Sorensen
Webbplats
Huvudkvarter
Malvern
Employees (FY)
7
Grundat
2009
FIGI
BBG00M0WD1J3
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
